Gilead could make a move for Galapagos within weeks

17:58 EST 17 Dec 2017 | pharmaphorum

The share price of Belgium-Dutch biotech Galapagos is rising thanks to renewed speculation that Gilead may be poised to acquire it. Gilead recently spent nearly $12 billion to acquire Kite Pharma and its groundbreaking CAR-T drug Yescarta, but man...

Original Article: Gilead could make a move for Galapagos within weeks


More From BioPortfolio on "Gilead could make a move for Galapagos within weeks"

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...